FABP4 in ovarian cancer (WP4400)
Homo sapiens
Regulation of FABP4 in ovarian cancer. FABP4 (fatty acid binding protein) can substantially increase metastatic potential of ovarian cancer cells, and leads to more aggressive disease. Mir-409-3p negatively regulates FABP4 in ovarian cancer cells, and mir-409-3p is decreased in hypoxic conditions. Pink arrows indicates potential therapuetic therapeutic stratgeies; in Gharpure et al, DOPC nanoliposomes containing either miR-409-3p mimic or FABP4 siRNA was shown to inhibit tumor progression. Description was adapted from Gharpure et al.
Authors
Kristina Hanspers and Friederike EhrhartActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
ExRNAAnnotations
Disease Ontology
ovarian cancerPathway Ontology
microRNA pathway cancer pathwayLabel | Type | Compact Identifier | Comment |
---|---|---|---|
FABP4 | GeneProduct | ensembl:ENSG00000170323 |
References
- FABP4 as a key determinant of metastatic potential of ovarian cancer. Gharpure KM, Pradeep S, Sans M, Rupaimoole R, Ivan C, Wu SY, et al. Nat Commun. 2018 Jul 26;9(1):2923. PubMed Europe PMC Scholia